4300 EL CAMINO REAL, SUITE 210, LOS ALTOS, CA
Director Resignation - Gaurav Aggarwal Steps Down from Board
Financial Results, Press Release
Other Events
Announces Third Quarter 2025 Financial Results and Provides Business Update
Provides Update from FDA Type A Meeting and Expects to Resubmit OLC NDA Before Year-End
Announces Second Quarter 2025 Financial Results and Provides Business Update
FY 2025
Q3
Q2
Q1
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(3)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report